Pancreatic Cancer Research

ResearcherMarche Polytechnic UniversityActive in the last 2 years

Francesco Piva

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1850-2482; OpenAlex author ID A5054063272. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 13

  1. PanSCOPE - Pancreatic cancer signature COllection for prognostic evaluation. Last author DOI 10.1016/j.pan.2025.11.001↗
  2. A Comparison of Tools That Identify Tumor Cells by Inferring Copy Number Variations from Single-Cell Experiments in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/biomedicines12081759↗
  3. Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility. Last author DOI 10.3390/ijms25010391↗
  4. Effects of the Exposure of Human Non-Tumour Cells to Sera of Pancreatic Cancer Patients. Last author DOI 10.3390/biomedicines10102588↗
  5. Role of primary cilium in pancreatic ductal adenocarcinoma (Review). Last author DOI 10.3892/ijo.2020.5121↗
  6. CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer? Last author DOI 10.1155/2019/9681698↗
  7. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival. Co-author DOI 10.3389/fonc.2019.00874↗
  8. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer. Last author DOI 10.1093/carcin/bgy069↗
  9. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis. Last author DOI 10.1007/s13402-017-0315-y↗
  10. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Last author DOI 10.1007/s13402-016-0283-7↗
  11. Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses. Co-author DOI 10.2217/fon.15.27↗
  12. KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma. First author DOI 10.2217/fon.15.98↗
  13. HER family receptor expression and prognosis in pancreatic cancer. Co-author DOI 10.5301/jbm.5000157↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matteo Giulietti · 10 shared papers, 2015–2025 · strength 1.91
  2. Daisy J. A. Oketch · 3 shared papers, 2023–2025 · strength 1.09
  3. Berina Šabanović · 3 shared papers, 2019–2022 · strength 0.48
  4. Alessandra Righetti · 2 shared papers, 2018–2019 · strength 0.23
  5. Alessandro Bittoni · 4 shared papers, 2015–2019 · strength 0.22
  6. Gaya Spolverato · 1 shared paper, 2022 · strength 0.17
  7. Kalliopi Andrikou · 3 shared papers, 2015 · strength 0.13
  8. Stefano Cascinu · 3 shared papers, 2015 · strength 0.13
  9. Consuelo Amantini · 1 shared paper, 2019 · strength 0.09
  10. Rossana Berardi · 1 shared paper, 2019 · strength 0.09
  11. Giorgio Santoni · 1 shared paper, 2019 · strength 0.09
  12. Massimo Nabissi · 1 shared paper, 2019 · strength 0.09
  13. Massimo Falconi · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.